Wag Group Co (NASDAQ: PET) has seen a rise in its stock price by 6.15 in relation to its previous close of 0.15. However, the company has experienced a 6.22% gain in its stock price over the last five trading sessions. globenewswire.com reported 2025-05-13 that VANCOUVER, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare and clinical stage drug development company, is pleased to announce it has entered into share exchange agreements to acquire 100% of the issued and outstanding shares of NoBrainer Imaging Centers, Inc. (“NIC”) (the “Transaction”). The Transaction moves Algernon into the Alzheimer’s Disease (“AD”) diagnostic and treatment market, expanding on the Company’s neurological research programs, and provides Algernon exclusive master franchise and licensing rights to open AD screening, diagnostic, and treatment centers across Canada and in multiple U.S. markets.
Is It Worth Investing in Wag Group Co (NASDAQ: PET) Right Now?
Company’s 36-month beta value is 1.06.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for PET is 24.65M, and currently, short sellers hold a 16.63% ratio of that floaft. The average trading volume of PET on May 14, 2025 was 4.02M shares.
PET’s Market Performance
PET’s stock has seen a 6.22% increase for the week, with a 29.04% rise in the past month and a -52.21% fall in the past quarter. The volatility ratio for the week is 10.39%, and the volatility levels for the past 30 days are at 19.62% for Wag Group Co The simple moving average for the past 20 days is 15.31% for PET’s stock, with a -64.65% simple moving average for the past 200 days.
Analysts’ Opinion of PET
Lake Street, on the other hand, stated in their research note that they expect to see PET reach a price target of $4. The rating they have provided for PET stocks is “Buy” according to the report published on May 30th, 2024.
Oppenheimer gave a rating of “Outperform” to PET, setting the target price at $5 in the report published on November 22nd of the previous year.
PET Trading at -5.25% from the 50-Day Moving Average
After a stumble in the market that brought PET to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -92.95% of loss for the given period.
Volatility was left at 19.62%, however, over the last 30 days, the volatility rate increased by 10.39%, as shares surge +26.50% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -37.76% lower at present.
During the last 5 trading sessions, PET rose by +1.90%, which changed the moving average for the period of 200-days by -87.65% in comparison to the 20-day moving average, which settled at $0.1403. In addition, Wag Group Co saw -31.93% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PET starting from Davidian Alec, who sale 22,719 shares at the price of $0.30 back on Feb 19 ’25. After this action, Davidian Alec now owns 795,971 shares of Wag Group Co, valued at $6,832 using the latest closing price.
Cane David, the Chief Customer Officer of Wag Group Co, sale 14,848 shares at $0.30 during a trade that took place back on Feb 19 ’25, which means that Cane David is holding 526,850 shares at $4,465 based on the most recent closing price.
Stock Fundamentals for PET
Current profitability levels for the company are sitting at:
- -0.2 for the present operating margin
- 0.93 for the gross margin
The net margin for Wag Group Co stands at -0.29. The total capital return value is set at 4.09. Equity return is now at value -3036.82, with -52.33 for asset returns.
Based on Wag Group Co (PET), the company’s capital structure generated 1.21 points at debt to capital in total, while cash flow to debt ratio is standing at -0.29. The debt to equity ratio resting at -5.67. The interest coverage ratio of the stock is -2.26.
Currently, EBITDA for the company is -8.83 million with net debt to EBITDA at -1.38. When we switch over and look at the enterprise to sales, we see a ratio of 0.35. The receivables turnover for the company is 11.29for trailing twelve months and the total asset turnover is 2.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.46.
Conclusion
In a nutshell, Wag Group Co (PET) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
